Geode Capital Management
PLXP

Geode Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Geode Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-237,491
Closed -$30.9K – 4866
2023
Q1 		$30.9K Hold
237,491
– – ﹤0.01% 4627
2022
Q4 		$38K Sell
237,491
-13,361
-5% -$5.59K ﹤0.01% 4669
2022
Q3 		$163K Buy
250,852
+6,874
+3% +$10.1K ﹤0.01% 4322
2022
Q2 		$592K Buy
243,978
+6,777
+3% +$18.8K ﹤0.01% 3675
2022
Q1 		$958K Buy
237,201
+21,039
+10% +$115K ﹤0.01% 3639
2021
Q4 		$1.73M Hold
216,162
– – ﹤0.01% 3443
2021
Q3 		$4.17M Buy
216,162
+15,321
+8% +$268K ﹤0.01% 3017
2021
Q2 		$2.77M Buy
200,841
+38,345
+24% +$454K ﹤0.01% 3172
2021
Q1 		$1.47M Buy
+162,496
New +$1.19M ﹤0.01% 3401
2017
Q2 		– Sell
-5,431
Closed -$56K – 4122
2017
Q1 		$56K Buy
5,431
+29
+0.5% +$315 ﹤0.01% 3932
2016
Q4 		$69K Buy
5,402
+19
+0.4% +$698 ﹤0.01% 3859
2016
Q3 		$624K Buy
5,383
+1,237
+30% +$121K ﹤0.01% 3161
2016
Q2 		$328K Hold
4,146
– – ﹤0.01% 3394
2016
Q1 		$315 Buy
4,146
+345
+9% +$21.9K ﹤0.01% 3448
2015
Q4 		$340K Buy
3,801
+9
+0.2% +$864 ﹤0.01% 3450
2015
Q3 		$424K Buy
3,792
+2,429
+178% +$280K ﹤0.01% 3291
2015
Q2 		$138K Hold
1,363
– – ﹤0.01% 3688
2015
Q1 		$148K Hold
1,363
– – ﹤0.01% 3666
2014
Q4 		$124K Hold
1,363
– – ﹤0.01% 3736
2014
Q3 		$108K Buy
+1,363
New +$104K ﹤0.01% 3736

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Geode Capital Management's PLXP Position: Q2 2023 in Review

Geode Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 237,491 shares — an estimated $30.9K sold.

Geode Capital Management first reported a position in PLXP in Q3 2014 and held it in 20 quarters. The position peaked at $4.17M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Geode Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Geode Capital Management sold 237,491 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $30.9K.
  • Geode Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q3 2014 and held it in 20 quarters.
  • Geode Capital Management's PLx Pharma Inc. Common Stock position peaked at $4.17M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.